Correlation Between ICD Co and Humasis

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ICD Co and Humasis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ICD Co and Humasis into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ICD Co and Humasis Co, you can compare the effects of market volatilities on ICD Co and Humasis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ICD Co with a short position of Humasis. Check out your portfolio center. Please also check ongoing floating volatility patterns of ICD Co and Humasis.

Diversification Opportunities for ICD Co and Humasis

-0.51
  Correlation Coefficient

Excellent diversification

The 3 months correlation between ICD and Humasis is -0.51. Overlapping area represents the amount of risk that can be diversified away by holding ICD Co and Humasis Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Humasis and ICD Co is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ICD Co are associated (or correlated) with Humasis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Humasis has no effect on the direction of ICD Co i.e., ICD Co and Humasis go up and down completely randomly.

Pair Corralation between ICD Co and Humasis

Assuming the 90 days trading horizon ICD Co is expected to under-perform the Humasis. But the stock apears to be less risky and, when comparing its historical volatility, ICD Co is 2.18 times less risky than Humasis. The stock trades about -0.13 of its potential returns per unit of risk. The Humasis Co is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  165,900  in Humasis Co on September 13, 2024 and sell it today you would earn a total of  19,200  from holding Humasis Co or generate 11.57% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

ICD Co  vs.  Humasis Co

 Performance 
       Timeline  
ICD Co 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ICD Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Humasis 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Humasis Co are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Humasis sustained solid returns over the last few months and may actually be approaching a breakup point.

ICD Co and Humasis Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with ICD Co and Humasis

The main advantage of trading using opposite ICD Co and Humasis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ICD Co position performs unexpectedly, Humasis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Humasis will offset losses from the drop in Humasis' long position.
The idea behind ICD Co and Humasis Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Other Complementary Tools

Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets